Niagen Bioscience (NAGE) Long-Term Deferred Tax (2016 - 2019)

Niagen Bioscience (NAGE) has reported Long-Term Deferred Tax for 4 consecutive years, with $218000.0 the latest figure, recorded in Q4 2019.

• In Q4 2019, Long-Term Deferred Tax fell 99.01% year-over-year to $218000.0; the TTM figure through Dec 2019 stood at $218000.0 (down 99.01% YoY), while the FY2019 annual figure was $218000.0, down 99.01% from the prior year.
• Long-Term Deferred Tax declined to $218000.0 in Q4 2019 per NAGE's latest filing, from $22.1 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $22.1 million in Q4 2018 and bottomed at $144000.0 in Q4 2017.
• Historically, Long-Term Deferred Tax has averaged $4.6 million across 4 years, with a median of $399000.0 in 2016.
• Annual changes were most pronounced in 2018 — Long-Term Deferred Tax jumped 15225.69% — and 2019, when it sank 99.01%.
• Niagen Bioscience's Long-Term Deferred Tax stood at $399000.0 in 2016, then sank by 63.91% to $144000.0 in 2017, then surged by 15225.69% to $22.1 million in 2018, then tumbled by 99.01% to $218000.0 in 2019.
• Business Quant data shows NAGE's Long-Term Deferred Tax at $218000.0 in Q4 2019, $22.1 million in Q4 2018, and $144000.0 in Q4 2017.